NPC2
NPC2 (NPC intracellular cholesterol transporter 2, also known as HE1, NP-C2 and EDDM1) is an intracellular cholesterol transporter that works with NPC1 to move cholesterol out of the lysosomal compartment. It belongs to the NPC2 family and contains a lipid recognition domain. Browse Assay Genie's current range of NPC2 research reagents below, or read on for the biology behind the target.
NPC2 is an intracellular cholesterol transporter that acts in concert with NPC1 and plays an important role in the egress of cholesterol from the lysosomal compartment. Unesterified cholesterol released from LDLs in the lumen of late endosomes and lysosomes is transferred by NPC2 to the cholesterol-binding pocket in the N-terminal domain of NPC1. NPC2 may also bind and mobilise cholesterol associated with membranes, and it binds cholesterol with a 1:1 stoichiometry.
The protein is not restricted to cholesterol. It can bind a variety of sterols, including lathosterol, desmosterol and the plant sterols stigmasterol and beta-sitosterol. UniProt records subcellular locations in the secreted fraction, the endoplasmic reticulum and the lysosome. The secreted form of NPC2 regulates biliary cholesterol secretion by stimulating ABCG5/ABCG8-mediated cholesterol transport. The mouse ortholog is Npc2.
The NPC2 gene encodes a protein containing a lipid recognition domain, and the HGNC places it in the MD-2 related lipid recognition domain containing group. It is also listed among microRNA protein coding host genes. NCBI Gene summarises the protein as possibly regulating cholesterol transport through the late endosomal/lysosomal system. Mutations in the gene have been associated with Niemann-Pick disease, type C2, which is the source of the previous name and the NP-C2 alias, and with frontal lobe atrophy. Researchers studying the NPC2 protein often examine it alongside NPC1.
NPC2 transfers cholesterol released from LDLs in late endosomes and lysosomes to NPC1, making it central to studies of cholesterol egress.
Mutations in the NPC2 gene are associated with Niemann-Pick disease, type C2, so the protein is a focus of disease-mechanism research.
Secreted NPC2 stimulates ABCG5/ABCG8-mediated cholesterol transport and so regulates biliary cholesterol secretion.
NPC2 binds cholesterol 1:1 and a range of other sterols, and may mobilise membrane-associated cholesterol.
NPC2 is an intracellular cholesterol transporter that acts with NPC1 to move cholesterol out of late endosomes and lysosomes. It passes unesterified cholesterol, released from LDLs, to the N-terminal cholesterol-binding pocket of NPC1. The secreted form also stimulates ABCG5/ABCG8-mediated biliary cholesterol secretion.
NPC2 is also called HE1, NP-C2 and EDDM1. Its previous HGNC name was Niemann-Pick disease, type C2, and the current full name is NPC intracellular cholesterol transporter 2. UniProt lists the protein as secreted, in the endoplasmic reticulum and in the lysosome.
Yes. Mutations in the NPC2 gene have been associated with Niemann-Pick disease, type C2 and with frontal lobe atrophy. The mouse has an ortholog called Npc2. Check the datasheet of any product for its validated reactivity.
Partner and related cholesterol transport proteins that work alongside NPC2 in sterol handling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P61916; product specifications from Assay Genie datasheets.